Four things to know about myosin light chains as reporters for non-muscle myosin-2 dynamics in live cells

Cytoskeleton

Volumn 72, Issue 2, 2015, Pages 65-70

  Heissler, Sarah M ^a   Sellers, James R ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Cell motility; GFP; Myosin; Phosphomimetics; Regulatory light chain

Indexed keywords

MYOSIN HEAVY CHAIN; MYOSIN II; MYOSIN LIGHT CHAIN; ACTIN;

DROSOPHILA; KINETICS; MOLECULAR DYNAMICS; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REPORTER GENE; ANIMAL; CELL MOTION; CYTOSKELETON; HUMAN; METABOLISM; MUSCLE CONTRACTION; PHOSPHORYLATION; PHYSIOLOGY;

EUKARYOTA;

ACTINS; ANIMALS; CELL MOVEMENT; CYTOSKELETON; HUMANS; MUSCLE CONTRACTION; MYOSIN HEAVY CHAINS; MYOSIN LIGHT CHAINS; PHOSPHORYLATION;

EID: 84927723164     PISSN: 19493584     EISSN: 19493592     Source Type: Journal    
DOI: 10.1002/cm.21212     Document Type: Note

References (48)

1. Bajaj G, Zhang Y, Schimerlik MI, Hau AM, Yang J, Filtz TM, Kioussi C, Ishmael JE. 2009. N-methyl-D-aspartate receptor subunits are non-myosin targets of myosin regulatory light chain. J Biol Chem 284:1252-1266.
2. Beach JR, Licate LS, Crish JF, Egelhoff TT. 2011. Analysis of the role of Ser1/Ser2/Thr9 phosphorylation on myosin II assembly and function in live cells. BMC Cell Biol 12:52
3. Beach JR, Shao L, Remmert K, Li D, Betzig E, Hammer JA, III. 2014. Nonmuscle myosin II isoforms coassemble in living cells. Curr Biol 24:1160-1166.
4. Billington N, Wang A, Mao J, Adelstein RS, Sellers JR. 2013. Characterization of three full-length human nonmuscle myosin II paralogs. J Biol Chem 288:33398-33410.
5. Bird JE, Takagi Y, Billington N, Strub MP, Sellers JR, Friedman TB. 2014. Chaperone-enhanced purification of unconventional myosin 15, a molecular motor specialized for stereocilia protein trafficking. Proc Natl Acad Sci U S A 111:12390-12395.
6. Bloemink M, Deacon J, Langer S, Vera C, Combs A, Leinwand L, Geeves MA. 2014. The hypertrophic cardiomyopathy myosin mutation R453C alters ATP binding and hydrolysis of human cardiac beta-myosin. J Biol Chem 289:5158-5167.
7. Bookwalter CS, Kelsen A, Leung JM, Ward GE, Trybus KM. 2014. A toxoplasma gondii class XIV myosin, expressed in Sf9 cells with a parasite Co-chaperone, requires two light chains for fast motility. J Biol Chem 289:30832-30841.
8. Bresnick AR. 1999. Molecular mechanisms of nonmuscle myosin-II regulation. Curr Opin Cell Biol 11:26-33.
9. Burnette DT, Manley S, Sengupta P, Sougrat R, Davidson MW, Kachar B, Lippincott-Schwartz J. 2011. A role for actin arcs in the leading-edge advance of migrating cells. Nat Cell Biol 13:371-381.
10. Chan W, Calderon G, Swift AL, Moseley J, Li S, Hosoya H, Arias IM, Ortiz DF. 2005. Myosin II regulatory light chain is required for trafficking of bile salt export protein to the apical membrane in Madin-darby canine kidney cells. J Biol Chem 280:23741-23747.
11. Espindola FS, Suter DM, Partata LB, Cao T, Wolenski JS, Cheney RE, King SM, Mooseker MS. 2000. The light chain composition of chicken brain myosin-va: calmodulin, myosin-II essential light chains, and 8-kDa dynein light chain/PIN. Cell Motil Cytoskeleton 47:269-281.
12. Franke JD, Boury AL, Gerald NJ, Kiehart DP. 2006. Native nonmuscle myosin II stability and light chain binding in drosophila melanogaster. Cell Motil Cytoskeleton 63:604-622.
13. Golomb E, Ma X, Jana SS, Preston YA, Kawamoto S, Shoham NG, Goldin E, Conti MA, Sellers JR, Adelstein RS. 2004. Identification and characterization of nonmuscle myosin II-C, a new member of the myosin II family. J Biol Chem 279:2800-2808.
14. Guzik-Lendrum S, Heissler SM, Billington N, Takagi Y, Yang Y, Knight PJ, Homsher E, Sellers JR. 2013. Mammalian myosin-18A, a highly divergent myosin. J Biol Chem 288:9532-9548.
15. Heissler SM, Manstein DJ. 2013. Nonmuscle myosin-2: mix and match. Cell Mol Life Sci 70:1-21.
16. Ikebe M. 1989. Phosphorylation of a second site for myosin light chain kinase on platelet myosin. Biochemistry 28:8750-8755.
17. Jordan P, Karess R. 1997. Myosin light chain-activating phosphorylation sites are required for oogenesis in drosophila. J Cell Biol 139:1805-1819.
18. Jung HS, Komatsu S, Ikebe M, Craig R. 2008. Head-head and head-tail interaction: a general mechanism for switching off myosin II activity in cells. Mol Biol Cell 19:3234-3242.
19. Kamisoyama H, Araki Y, Ikebe M. 1994. Mutagenesis of the phosphorylation site (serine 19) of smooth muscle myosin regulatory light chain and its effects on the properties of myosin. Biochemistry 33:840-847.
20. Kengyel A, Wolf WA, Chisholm RL, Sellers JR. 2010. Nonmuscle myosin IIA with a GFP fused to the N-terminus of the regulatory light chain is regulated normally. J Muscle Res Cell Motil 31:163-170.
21. Komatsu S, Yano T, Shibata M, Tuft RA, Ikebe M. 2000. Effects of the regulatory light chain phosphorylation of myosin II on mitosis and cytokinesis of mammalian cells. J Biol Chem 275:34512-34520.
22. Kondo T, Isoda R, Uchimura T, Sugiyama M, Hamao K, Hosoya H. 2012. Diphosphorylated but not monophosphorylated myosin II regulatory light chain localizes to the midzone without its heavy chain during cytokinesis. Biochem Biophys Res Commun 417:686-691.
23. Ledee DR, Tripathi BK, Zelenka PS. 2007. The CDK5 activator, p39, binds specifically to myosin essential light chain. Biochem Biophys Res Commun 354:1034-1039.
24. Lu Z, Ma XN, Zhang HM, Ji HH, Ding H, Zhang J, Luo D, Sun Y, Li XD. 2014. Mouse myosin-19 is a plus-end-directed, high-duty ratio molecular motor. J Biol Chem 289:18535-18548.
25. Ma X, Adelstein RS. 2014a. A point mutation in Myh10 causes major defects in heart development and body wall closure. Circ Cardiovasc Genet 7:257-265.
26. Ma X, Adelstein RS. 2014b. The role of vertebrate nonmuscle myosin II in development and human disease. Bioarchitecture 4:88-102.
27. Ma X, Kawamoto S, Hara Y, Adelstein RS. 2004. A point mutation in the motor domain of nonmuscle myosin II-B impairs migration of distinct groups of neurons. Mol Biol Cell 15:2568-2579.
28. Ma X, Jana SS, Conti MA, Kawamoto S, Claycomb WC, Adelstein RS. 2010. Ablation of nonmuscle myosin II-B and II-C reveals a role for nonmuscle myosin II in cardiac myocyte karyokinesis. Mol Biol Cell 21:3952-3962.
29. Maliga Z, Junqueira M, Toyoda Y, Ettinger A, Mora-Bermudez F, Klemm RW, Vasilj A, Guhr E, Ibarlucea-Benitez I, Poser I, et al. 2013. A genomic toolkit to investigate kinesin and myosin motor function in cells. Nat Cell Biol 15(3):325-334.
30. Maupin P, Phillips CL, Adelstein RS, Pollard TD. 1994. Differential localization of myosin-II isozymes in human cultured cells and blood cells. J Cell Sci 107(Pt11):3077-3090.
31. Nagy A, Takagi Y, Billington N, Sun SA, Hong DK, Homsher E, Wang A, Sellers JR. 2013. Kinetic characterization of nonmuscle myosin IIb at the single molecule level. J Biol Chem 288:709-722.
32. Peterson LJ, Rajfur Z, Maddox AS, Freel CD, Chen Y, Edlund M, Otey C, Burridge K. 2004. Simultaneous stretching and contraction of stress fibers in vivo. Mol Biol Cell 15:3497-3508.
33. Post PL, DeBiasio RL, Taylor DL. 1995. A fluorescent protein biosensor of myosin II regulatory light chain phosphorylation reports a gradient of phosphorylated myosin II in migrating cells. Mol Biol Cell 6:1755-1768.
34. Rayment I, Rypniewski WR, Schmidt-Base K, Smith R, Tomchick DR, Benning MM, Winkelmann DA, Wesenberg G, Holden HM. 1993. Three-dimensional structure of myosin subfragment-1: a molecular motor. Science 261:50-58.
35. Scholey JM, Taylor KA, Kendrick-Jones J. 1980. Regulation of non-muscle myosin assembly by calmodulin-dependent light chain kinase. Nature 287:233-235.
36. Schramek D, Sendoel A, Segal JP, Beronja S, Heller E, Oristian D, Reva B, Fuchs E. 2014. Direct in vivo RNAi screen unveils myosin IIa as a tumor suppressor of squamous cell carcinomas. Science 343:309-313.
37. Sellers JR. 1991. Regulation of cytoplasmic and smooth muscle myosin. Curr Opin Cell Biol 3:98-104.
38. Shutova MS, Spessott WA, Giraudo CG, Svitkina T. 2014. Endogenous species of mammalian nonmuscle myosin IIA and IIB include activated monomers and heteropolymers. Curr Biol 24:1958-1968.
39. Sommese RF, Sung J, Nag S, Sutton S, Deacon JC, Choe E, Leinwand LA, Ruppel K, Spudich JA. 2013. Molecular consequences of the R453C hypertrophic cardiomyopathy mutation on human beta-cardiac myosin motor function. Proc Natl Acad Sci U S A 110:12607-12612.
40. Sweeney HL, Yang Z, Zhi G, Stull JT, Trybus KM. 1994. Charge replacement near the phosphorylatable serine of the myosin regulatory light chain mimics aspects of phosphorylation. Proc Natl Acad Sci U S A 91:1490-1494.
41. Szymanski PT, Goyal RK. 1999. Calponin binds to the 20-kilodalton regulatory light chain of myosin. Biochemistry 38:3778-3784.
42. Tan I, Yong J, Dong JM, Lim L, Leung T. 2008. A tripartite complex containing MRCK modulates lamellar actomyosin retrograde flow. Cell 135:123-136.
43. Valouev IA, Urakov VN, Kochneva-Pervukhova NV, Smirnov VN, Ter-Avanesyan MD. 2004. Translation termination factors function outside of translation: yeast eRF1 interacts with myosin light chain, Mlc1p, to effect cytokinesis. Mol Microbiol 53:687-696.
44. Vasquez CG, Tworoger M, Martin AC. 2014. Dynamic myosin phosphorylation regulates contractile pulses and tissue integrity during epithelial morphogenesis. J Cell Biol 206:435-450.
45. Vicente-Manzanares M, Ma X, Adelstein RS, Horwitz AR. 2009. Non-muscle myosin II takes centre stage in cell adhesion and migration. Nat Rev Mol Cell Biol 10:778-790.
46. Watanabe N, Mitchison TJ. 2002. Single-molecule speckle analysis of actin filament turnover in lamellipodia. Science 295:1083-1086.
47. Weissbach L, Bernards A, Herion DW. 1998. Binding of myosin essential light chain to the cytoskeleton-associated protein IQGAP1. Biochem Biophys Res Commun 251:269-276.
48. Zhang Y, Yu LC. 2008. Single-cell microinjection technology in cell biology. BioEssays 30:606-610.